An experimental melanoma vaccine could reduce the risk of the cancer returning or spreading for some high-risk patients. It's personalized for each patient and optimized using artificial intelligence. Dr. Jon LaPook has more details.
An experimental melanoma vaccine could reduce the risk of the cancer returning or spreading for some high-risk patients. It's personalized for each patient and optimized using artificial intelligence. Dr. Jon LaPook has more details.
<iframe src="https://statesidedaily.com/embed/cluster/7d138e661f62915ba24af0019666669cc38484cb" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Experimental melanoma vaccine shows promising results"></iframe>
